Literature DB >> 1821205

Long-term follow-up study of nonsenile detachment of the retinal pigment epithelium.

L Laatikainen1, M Hoffren.   

Abstract

Re-assessment of a series of fluorescein angiograms of 76 patients referred to our hospital for central serous retinopathy (CSR) between 1973 and 1982 revealed 10 eyes of 8 patients (7 males, 1 female) aged 50 years or younger (mean age 42.6 years, median 43.5, range 36-49) with serous detachment of the retinal pigment epithelium (PED) with (3 eyes) or without (7 eyes) detachment of the neuroretina. Two eyes had two discrete PEDs and two eyes showed minor pigmentary disturbance outside the PED. In the remaining six eyes no other pigment epithelial (PE) changes were observed. In five patients no PE changes were found in the fellow eye. During the follow-up period of 2.8 to 14.3 years (mean 7.3, median 6.4) three eyes had one recurrence of symptoms. The long-term prognosis was good. None of the eyes developed subretinal neovascularization or geographic atrophy, in eight eyes PED flattened with a mild degree of pigment dispersion at the site, two eyes had persistent shallow PED. The latest visual acuity was 1.0 or better in nine eyes, and 0.6 in one. It is concluded that no treatment of nonsenile PED seems to be warranted.

Entities:  

Mesh:

Year:  1991        PMID: 1821205     DOI: 10.1177/112067219100100205

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   1.922


  3 in total

1.  Pattern ERG in central serous retinopathy.

Authors:  Jawahar Lal Goyal; Basudeb Ghosh; Vishram Sangit; Sushil Kumar; Parul Jain; Vikas Veerwal; Ritu Arora
Journal:  Doc Ophthalmol       Date:  2014-12-27       Impact factor: 2.379

2.  The pathology of whiplash maculopathy and retinopathy : Illustrated observations derived from a fatal roller-coaster accident.

Authors:  M A Parsons; J F Talbot; H S Mudhar; Guy N Rutty
Journal:  Forensic Sci Med Pathol       Date:  2005-03       Impact factor: 2.007

3.  Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level.

Authors:  W-M Chan; D S C Lam; T Y Y Lai; B S M Tam; D T L Liu; C K M Chan
Journal:  Br J Ophthalmol       Date:  2003-12       Impact factor: 4.638

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.